Formycon AG (FYB) - Total Liabilities

Latest as of December 2025: €340.39 Million EUR ≈ $397.95 Million USD

Based on the latest financial reports, Formycon AG (FYB) has total liabilities worth €340.39 Million EUR (≈ $397.95 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore FYB year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Formycon AG - Total Liabilities Trend (2009–2025)

This chart illustrates how Formycon AG's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Formycon AG to measure how efficiently the company converts operating cash flow to free cash.

Formycon AG Competitors by Total Liabilities

The table below lists competitors of Formycon AG ranked by their total liabilities.

Company	Country	Total Liabilities
Ascencio (D) BR:ASCE	Belgium	€367.49 Million
Shenzhen King Brother Electronics Technology Co.Ltd. SHE:301041	China	CN¥259.98 Million
Fagerhult AB ST:FAG	Sweden	Skr6.56 Billion
Ratos AB (publ) ST:RATO-A	Sweden	Skr13.77 Billion
Palisade Bio Inc NASDAQ:PALI	USA	$5.95 Million
BRASI.CIA BRAS.D.PROP.ADR F:52BA	Germany	€1.66 Billion
Alucon Public Company Limited BK:ALUCON	Thailand	฿964.96 Million

Liability Composition Analysis (2009–2025)

This chart breaks down Formycon AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see FYB market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.33	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.85	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.46	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Formycon AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Formycon AG (2009–2025)

The table below shows the annual total liabilities of Formycon AG from 2009 to 2025.

Year	Total Liabilities	Change
2025-12-31	€340.39 Million ≈ $397.95 Million	+9.85%
2024-12-31	€309.87 Million ≈ $362.27 Million	-20.06%
2023-12-31	€387.61 Million ≈ $453.16 Million	-22.03%
2022-12-31	€497.12 Million ≈ $581.18 Million	+3253.46%
2021-12-31	€14.82 Million ≈ $17.33 Million	+96.00%
2020-12-31	€7.56 Million ≈ $8.84 Million	+41.51%
2019-12-31	€5.34 Million ≈ $6.25 Million	-16.28%
2018-12-31	€6.38 Million ≈ $7.46 Million	+20.82%
2017-12-31	€5.28 Million ≈ $6.18 Million	+23.03%
2016-12-31	€4.29 Million ≈ $5.02 Million	+88.68%
2015-12-31	€2.28 Million ≈ $2.66 Million	-30.28%
2014-12-31	€3.26 Million ≈ $3.82 Million	+2.22%
2013-12-31	€3.19 Million ≈ $3.73 Million	-5.48%
2012-12-31	€3.38 Million ≈ $3.95 Million	+639.50%
2011-12-31	€457.00K ≈ $534.28K	+118.40%
2010-12-31	€209.25K ≈ $244.64K	+243.03%
2009-12-31	€61.00K ≈ $71.32K	--

About Formycon AG

XETRA:FYB Germany Biotechnology

Market Cap

$392.57 Million

€335.79 Million EUR

Market Cap Rank

#14166 Global

#1431 in Germany

Share Price

€19.00

Change (1 day)

-0.94%

52-Week Range

€16.82 - €26.10

All Time High

€92.50